Born in Switzerland during the posting of his British parents with the British Consulate General in Zurich, he went through his schooling in Switzerland and initially studied Veterinary medicine at the University of Zurich, obtaining his diploma as veterinary surgeon and Doctor of Veterinary Medicine in 1982. His first PhD entitled “Parathyroid cell variants may be provoked during immersion fixation” was done in 1987 and earned him Fellow of the Royal Microscopical Society FRMS. After studying Comparative Ophthalmology, resulting in a second PhD thesis and his Doctor title from the University of Zurich on “Mesodermal Goniodysgenesis in the Siberian Husky”, he started work at Dispersa AG, later Ciba Vision Ophthalmics and Novartis Ophthalmics as a medical consultant, drugs regulatory affair and later becoming Vice President and responsible head of Medical Affairs. During this time, he developed his first interests in stem cells, leading to research projects into adults mesenchymal stem cells from bone marrow and adipose tissue to treat ophthalmic conditions such as AMD, Keratoconjunctivitis sicca and glaucoma. He then set up his own company, Med Cell Europe, where first treatment of stem cell transplants, GMP conform production methods and a whole range of research was performed. This lead to one of the first treatment and stem cell laboratories in Switzerland, several patents on the production of exosomes and paracrine substances by mesenchymal stem cells and the development of treatments with Dendritic Cells, the successful transformation of mesenchymal stem cells into dopamine and insulin producing cells. Dr Kellner is now founder and chief scientist of Mesencell Biotech, which focuses on autologous stem cell and dendritic cell treatments in the Middle East and Northern Africa, co-founder and chief scientist of Med Cell Bahamas with a government licence for stem cell treatments in the Bahamas, co-founder and chief scientist of Med Cell International in the USA and co-founder, board member and chief scientist of Med Cell plc responsible for worldwide research projects and clinical trials for diseases such as Alzheimer Disease, Parkinson Disease, Diabetes T1 and T2 and osteoarthritis. Apart from his main research focus into neurological disease (Alzheimer and Parkinson Disease and retinal disease) Dr Kellner mentors young biotech start-up companies and actively seeks and finds collaboration with other research institutes and local governments.

Mesenchymal Stem Cells: Increasing neurotrophic substances in the secretome produced by mesenchymal stem cells (MSCs), Treatment of Alzheimer Disease with MSCs, Treatment of Parkinson Disease with Dopamine producing cells, Treatment of Age related macular degeneration with MSCs. Dendritic Cells: Treatment of Multiple Sclerosis, prostate cancer, cancer prevention Biomarkers: Development of biomarkers for the diagnosis and monitoring of Alzheimer Disease, Parkinson Disease, osteoarthritis and ageing/morbidity Other Cells: transfected MSCs, induced pluripotent stem cells, olfactory ensheathing cells, MUSE cells

1. Executive Committee of the International Neuropsychiatric Association (INA) 2. Executive Committee of the Asian Society Against Dementia (ASAD) 3. Councilor of the Japanese Society of Cognitive Neuroscience 4. Councilor of the Japan Society for Higher Brain Dysfunction 5. Councilor of the Neuropsychology Association of Japan 6. Councilor of the Japan Psychogeriatric Association 7. Councilor of the Japan Society for Dementia Research

Board of Internal Medicine, Clinical Neurology, Stroke Medicine, Geriatric Psychiatry, and Dementia Medicine certified by the Japanese Societies of Internal Medicine, Neurology, Stroke, Psychogeriatric, and Dementia Association

Dr. Zhan received his undergraduate and graduate training in the fields of preventive medicine and epidemiology and statistics at the West China University of Medical Sciences in China during 1989 to 1999. He received his post-doctoral training in oncology and cancer proteomics for two years at the Cancer Research Institute of Human Medical University in China. In 2001, he went to the University of Tennessee Health Science Center (UTHSC) in USA, where he was a post-doctoral researcher and focused on mass spectrometry and cancer proteomics. Then, he was appointed as an Assistant Professor of Neurology, UTHSC in 2005. He moved to the Cleveland Clinic in USA as a Project Scientist/Staff in 2006 where he focused on the studies of eye disease proteomics and biomarkers. He returned to UTHSC as an Assistant Professor of Neurology in the end of 2007, engaging in proteomics and biomarker studies of lung diseases and brain tumors, and initiating the studies of predictive, preventive, and personalized medicine (PPPM) in cancer. In 2010, he was promoted to Associate Professor of Neurology, UTHSC. Currently, he is a Professor at Xiangya Hospital of Central South University in China, the European EPMA National Representative in China, Associate Editors of BMC Genomics and of BMC Medical Genomics. He has published 79 peer-reviewed research articles including about 55 articles in the field of disease proteomics and transcriptomics, 7 book chapters, and 2 US patents.

His current main research interest focuses on the studies of cancer proteomics and biomarkers, and the use of modern omics techniques and systems biology for PPPM in cancer.

As physician-scientist with specialty and expertise in neurology and neuropathology, especially in the field of neurodegenerative diseases (dementias and movement disorders) and more recently TBI, I feel particularly suitable for this proposal. I have centered my clinical and research career in the study of neurodegenerative diseases and more recently on the neurodegenerative and neuropsychiatric consequences related to these disorders. My previous clinical activities have focused on patients affected by dementias, movement disorders, and epilepsy; while my post-doctoral research fellowship in the Division of Neuropathology at Johns Hopkins University was focused on studies related to normal aging and neurodegenerative diseases. I have worked in some of the premier European institutions for neurology throughout Switzerland, France, and the UK. Prior to joining CNRM/USUHS, I have worked at the Atlantic Health System, NJ, Icahn School of Medicine at Mount Sinai, NY and served as Senior Researcher and Head of The Brain Bank at Karolinska Institutet, Sweden. I have authored over 30 articles in many high-impact journals and have received a series of research grants for young investigators. I have a great deal of experience related to the stereological analyses of human brain tissue and clinicopathologic correlation studies. In particular, I am familiar with clinical and neuropathologic diagnoses, current clinical and pathologic criteria for dementias, movement disorders, and CTE, with quantifying morphometric and immunohistochemistry aspects as assessed in different human brain regions. I have previously worked on the Baltimore Longitudinal Study of Aging, the Nun Study, and the Swedish Twin Study individuating and publishing novel data on peculiar aspects of the human brain resilience against the presence (autopsy-confirmed) of multiple pathology such as AD pathology in asymptomatic older subjects for dementia; and I started to be funded in support of genomic analyses using human brains. Now, as associate professor and deputy director of the BTR and Neuropathology Core at CNRM/USUHS I am really excited about the opportunity to apply all my skills and knowledge to the TBI field and to expand my studies on neurodegeneration getting direct access to the largest brain collection of Guam disease cases (including ALS, PD and AD) existing in the world. Thanks to the very rare, probably unique, opportunity to study Guam brains using new immunohistochemistry methods, genetic procedures and toxicological tools I am eager to possibly shed light on gene-environmental risk for sporadic ALS, and neurodegeneration in general.

1) Neurodegenerative diseases (dementias and movement disorders): clinical and clinical research aspects; 2) Neuropathology of dementias and movement disorders; 3) Traumatic brain injury-related dementias;

Professor Mohammed Sallam is working as a professor of Organic Chemistry Faculty of Science, Alexandria University. He got his PhD from Alexandria University, Then He got several Postdoctoral fellowships and Visiting Scientist at Biochemistry Department Purdue University, Medicinal Chemistry, Michigan State University, Medicinal Chemistry, Ohio State University, Department of Chemistry, University of Trondheim, Norway. He is Board editor at several Journals; J. of Carbohydrate Chemistry, 1983-2000, Green and Sustainable Chemistry, GSC, 2011-present, and Vitamins and Minerals Reports, November 2013- 2014 ( the Journal discontinued).

His Major field is Carbohydrates and C-nucleosides and Circular Dichroism Spectroscopy

Dr. Murat Senturk obtained a Baccalaureate a degree in Chemistry in 2002, a Master degree in Biochemistry in 2006 and a Doctorate degree in Biochemistry in 2009 from Atatürk University, Turkey. Dr. Senturk currently works as an Associate Professor of Biochemistry in Department of Biochemistry, Division of Pharmaceutical Basic Sciences, Faculty of Pharmacy, Agri Ibrahim Cecen University, Turkey. Dr. Senturk published over ninety scientific papers, review and book chapters and presented several conferences to scientists. His research interests span enzyme inhibitor or activator, protein expression, purification and characterization, drug design and synthesis, toxicology and pharmacology. His research work has focused on antioxidant and metabolic enzyme systems. Dr. Senturk serves as the Editorial Board of several international journals.

Drug design and synthesis, Animal and human physiology, Medical application of natural molecules, Nanobiotechnology applications, Green Chemisrty, Enzyme Kinetic, Toxicology, Cancer Biochemistry.

Seung-Yong Seong has completed his degree, M.S, and Ph.D. from Seoul National University College of Medicine in the Department of Microbiology and Immunology. Currently, he is working as a professor at Seoul National University College of Medicine in the Department of Microbiology and Immunology. He authored many publications in esteemed journals. He is an active member of various societies such as Korean Society for Microbiology, Korean Society for Immunology, American Society for Microbiology, and American Society for Immunology. He received many national and international awards for his contribution in the field of microbiology and immunology.

Anti-cancer immunotherapeutics have been developed for last couple of years and showed promising results. Nonetheless, there are many obstacles to overcome. We have tried to enhance antigen delivery into DCs by using nanoparticles and published on Nature Nanotech 2011. In addition, one of main hurdles is to identify tumor-specific target antigens to evoke successful cancer-specific immune responses. We have been trying to identify stem-cell specific antigens by comparing gene expression profiles between induced pluripotent stem cells and parental cells. Among the stem-cell-specific antigens, we identified tumor-associated antigens by analyzing SAGE database and by immunohistochemistry using normal tissue arrays and cancer arrays. We have been investigating their therapeutic potential as target antigens in immunotherapy using dendritic cells (DCs) vaccine and antibody therapeutics-targeting cancer-stem cell antigens in mouse tumor model. In addition, we have been trying to find out new molecular entities that control inflammation based on our novel views published on Nature Rev. Immunol 2004.

Dr. Guan received a PhD in pharmacology from Sun Yat-sen University in China in 2007. Just after receiving her education, Dr. Guan pursued her postdoctoral training in Department of Neuro-oncology MD Anderson Cancer Center in USA. In 2009, she came back to China to start her academic career. She is currently an associate professor in South China University of Technology. Her professional interests focus on pharmacology and mechanism of New Drugs, identification of biomarkers and new targets in major diseases, drug metabolism and metabolomics. She has published more than 30 papers in SCI journal focus on pharmacology and pharmacodynamics aspects of new compounds. And she is in charge of and participate nearly 10 funds of national, provincial and ministerial level. She is currently a member of International Society for the Study of Xenobiotics and a member of Chinese Pharmacological Society.

Study on Pharmacology and Mechanism of New Drugs, identification of biomarkers and new targets in major diseases, drug metabolism and metabolomics. Have published more than 30 papers in SCI and the domestic core journals focus on pharmacology and pharmacodynamics aspects of new compounds, including 10 first author and corresponding author SCI articles. In charge of and participate nearly 10 funds of national, provincial and ministerial level.

I am pleased to introduce myself as Dr Bharti mittu. I did Doctorate in Philosophy from Patiala University Department of Biotechnology and presently working with Pharmaceutical Institute of National Importance from last 13 years.My area of expertise Analytical Chemistry, Clinical Microbiology, Pharmaceutical microbiology. Research experience is on “A STUDY ON ANTI-GARDNERELLA VAGINALIS BACTERIOCIN PRODUCING HUMAN VAGINAL LAB ISOLATE” During my studies I have isolated novel protein (bacteriocin) and did its characterization and evaluation. Biomedical applications of various bacteriocins and probiotics Cytotoxicity studies of bacteriocin Handled most sophisticated instruments. Work done on Protein Purification, Amino acid sequencing and Isolation and Characterization of microbes.  Vast experience in thermal analytical techniques, chromatographic techniques and their various applications in Pharma. Food and Biomedical Science. I have numerous international publications of research and review articles in high impact Journals. I have contributed a number of research articles for International and National Conferences, Editorial Articles for the esteemed Journals. I am associated as an active member in scientific associations. I am member of Advisory Board, Editorial Board and Acknowledged reviewer of many International Scientific Journals.

My area of expertise Analytical Chemistry, Clinical Microbiology, Pharmaceutical microbiology.

Dr. Mohammed Rachidi received his PhD/ Doctorate Degree in Human and Molecular Genetics (with High Honors) at the prestigious ''Pasteur Institute'' (Paris, France), in the Department of Molecular and Cellular Genetics headed by the Professor François JACOB (Nobel Prize in Physiology/Medicine), where he studied the Cellular & Molecular Mechanisms underlying Brain Morphogenesis, Visual System development, CaMKinases & Biological Clock Function in Drosophila. Dr. Rachidi extended these Molecular Genetics works to Functional Genomics at Pasteur Institute and at Center National of Research Scientific CNRS and played key fundamental roles in different collaborative research projects with prestigious laboratories in Europe, Japan & United States. Remarkably, Dr. Rachidi collaborated with the Professor Michael ROSBASH (Nobel Prize in Physiology/Medicine 2017) in the Molecular Mechanisms of 2 genes involved in Circadian Clock. Dr. Rachidi published with Professor ROSBASH this important work in the EMBO Journal Entitled : ''A New Gene encoding a putative Transcritpion Factor Regulated by the Drosophila Circadian Clock''. Postdoctoral training & Assistant Professor with Professor Nicole LeDOUARIN at the prestigious ''College De France'' & Institute of Cellular & Molecular Embryology (Paris), Dr. Rachidi studied some Chicken & Xenopus molecules acting in Bone Morphogenetic Protein BMP signaling pathways and identified their Mouse & Human homologs involved in differentiation of specific domains of neuronal progenitors, in cerebellum development and Joubert syndrome (a form of cerebellar ataxia). These experiences of Dr. Rachidi in the Molecular Genetics and in several Animal Models were extended to Human Molecular Genetics of Down syndrome (DS) & to Molecular and Cellular Mechanisms underlying Brain morphogenesis of Trisomic & Transgenic Mouse Models of DS and also of numerous stages of Embryonic & Fetal DS patients to elucidate the Neurogenetic Basis of Functional alterations Associated with Mental Retardation.

Dr. Rachidi has vast experiences with different Research Interests in Modern Molecular Genetics, Neuroscience & Biomedical Research, to name a few : Cellular & Molecular Mechanisms underlying Brain Morphogenesis, Visual System, Biological Clock, Synaptic Protein Targeting, Synaptic Plasticity, CaMKII & CAMGUK/MAGUK, Learning and Memory. Functional Genomics & Mechanisms controlling Transposition at Cell Cycle. Transcription, Protein Translation & Virus-Like Particle Formation. Bone Morphogenetic Protein BMP signaling pathways, Mouse and Human Homeobox Genes, Cell Fate Determination and Differentiation, Neuronal Progenitors in Cerebellum development and Joubert syndrome. Trisomy 21, Intellectual Disability, Candidate Genes, Expression studies, Genotype-Phenotype Associations, Trisomic and Transgenic Mouse Models of Down syndrome, Neurogenetic and Neurocognitive Basis of Functional Impairments Associated with Intellectual Disability. Drosophila & Mouse & Human.

President Chen obtained PhD in 1999 at Kaohsiung Medical University. Currently teaches in Fooyin University, as most young is also the most senior professors and deans. The past 20 years, he has his scientific interests focused on life-threatening diseases, including traditional Chinese medicine used for cancer research. Analysis in recent year’s major active ingredients such as ginger, pepper and cinnamon used in gastrointestinal cancer, anti-inflammatory, antioxidant, antiparasitic, and other topics. President Chen specializes in isolation, purification and structural analysis of active components of plants. President Chen directed against active constituents of oral cancer, liver cancer, and rectal cancer. President Chen was just over 45 years old, but his work has more than 220 papers, Taiwan one of the young talents. Professor Chen was invited more than 170 kinds of Journal editorial boards. Professor Chen won numerous awards at home and abroad, from 2015, was awarded the lifetime achievement award; from 2016 was awarded the health care & biotechnology merit award.

Pharmacognosy, Natural Products, Chinese Medicine, Natural Product Research

Dr. Zhi Dong Zhou is graduated as a medical doctor in 1991 and had 5 years of postgraduate clinical training in internal medicine in China. Subsequently he acquired Ph.D from Chinese Academy of Science, Shanghai Branch and started his research career in Singapore on dopamine (DA) neuron degeneration in Parkinson's disease (PD). Later he joined the National Neuroscience Institute (NNI) as a member of the Singapore National PD Translational Bench to Bedside team and continue to work on DA neuron degeneration in PD. Currently, he is an Associate Clinician Scientist in charge of the Translational Therapeutics Laboratory of NNI and an Assistant Professor at Duke-NUS, NBD as well as a PI of NMRC and SHF grants.

Translational Neuroscience researches on neuron degeneration in Parkinson's disease (PD), Alzheimer’s disease (AD) and other human neurodegenerative disorders.

I work in academia as an internationally recognized neuropharmacology and neuroimmunology researcher. I published more than 500 scientific reports in the field of neuropsychopharmacology and signal transduction . I am leading a laboratory interested in understanding the fundamental neurobiological mechanisms of neuropsychiatric disorders to contribute at development of new pharmacological treatments. We use genetic, neuroendocrine and neurochemical methods. We recognize the role of the immune system in modulating neuropsychiatric diseases and we are developing in vitro cellular models and in vivo animal models to study the neuro-immune interactions under normal and disease states I has successfully combined research, teaching, administration and clinical care and continue to work on advancing our understanding of serious mental illness and drug development. We used to translate research findings into medical practice for the purposes of diagnosing, preventing and treating diseases. I has published scientific reports on peptides, their receptors, signal transduction and the role of these neuropeptides in the immune systems. I hold patents for using modified peptides in the treatment of septic shock.

I have skills and expertise in receptor pharmacology, immunohistochemistry, in vivo and in vitro cell culture, biochemistry, animal models, cell and molecular biology. I has lectured worldwide on these subjects and the others. I have 19 years of research experience with development and use of in vitro models to test compounds, such as receptor binding, receptor activation, signal transduction, receptor-receptor interactions, and induction of changes in cell cycle, proliferation and apoptosis. Furthermore I validated appropriate assays and models of diseases, screen compounds, and study mechanisms of action.

Stavros J.Baloyannis is Emeritus Professor of Neurology at Aristotelian University, Thessaloniki, Greece. He was born in Thessaloniki. He graduated from the School of Medicine, Aristotelian University, Thessaloniki, Greece. Postgraduate training (a) in Neurology, Aristotelian University and Institute of Neurology, Queen Square, London, (b) in Neuropathology, Institute of Neurology, Queen Square, Catholic University of Louvain, University of Pennsylvania, Philadelphia (c) in Neurootology and Neuropathology of Auditory pathway, Harvard University, (d) in Neuropathology and Experimental Neurology, University of Pennsylvania, (e) in Neuroimmunology, Yale University, New Haven. Research on Blood Brain Barrier in dementias and Demyelinating diseases, Mitochondria in Alzheimer’s disease, Synaptogenesis in vivo and in vitro, Neuronal apoptosis in dementias and demyelinating diseases, dendritic pathology in dementias, Pathology of Golgi apparatus in dementias. Special interests: Neuroethics, Neurolinguistics, Philosophy of Neurosciences, Application of mathematics in Neurosciences, Neurology and the Art. Member of 56 scientific societies in Greece and abroad. Honorary Member of the Academy of Hellenic Air Forces. President of the Society for the amelioration of the quality of life in chronic neurological diseases. President of the Orthodox Medical Association for Health and medical education in Africa. Visiting professor in Tufts University, Democretian University, Thrace, Aristotelian University, School of Theology, Aristotelian University, School of Philosophy. Author of 28 textbooks on Neurology, Neuropathology, Neuropsychology and of 720 peer-reviewed papers, published in Greek and International Journals on Neurology, Neuropathology, Neuroimmunology and Neuroethics.

Electron microscopy, mitochondria, Golgi apparatus, Alzheimer’s disease, synapses, neuronal plasticity, neurophilosophy, neurology and the arts

Full Professor of Physiological Psychology at the Department of Psychology - University of Rome “ Sapienza”, and Director of the Sleep Laboratory of University of Rome Sapienza. Author of more than 130 articles on international peer-reviewed journals (Total I.F.= ~ 450; H-index ISI=32 Scopus=36 Google Scholar=43 ORCID ID: orcid.org/0000-0003-3613-6631; Publons: https://publons.com/author/668323/luigi-de-gennaro - profile). He is Associate Editor of Journal of Sleep Research, and member of the Editorial Board of many journals (Frontiers of Psychology, Frontiers in Neurogenomics, Neural Regeneration Research, Medicine and Disorders International, Open Journal of Neuroscience, Open Medical Imaging Journal, World Journal of Neurology, World Journal of Radiology, Journal of Clinical Cases, International Journal of Neurology Research, JOURNAL OF HEALTH AND SOCIAL SCIENCES, Sleep Spindles & Cortical Up States). Reviewer of the several journals (among these: Science, Nature Communications, J Sleep Res; Cer Cortex; Sleep Med Rev; Neuroimage; Journal of Neuroscience; Human Brain Mapping; Brain Topograph).

His main Topics in Sleep Research are: (1) Neurophysiology (Heritability, Excitability of motor cortex, Cortico-Hippocampal networks, Corpus callosum, Sleep fragmentation, Sleep onset, Sleep inertia, Sleepiness, Oculomotor system, Placebo effect, Dream recall, Personality correlates of dreaming, Sptial learning and memory, Exposure to GSM fields); Pathologies (Sleep disorders; Depression; Alzheimer Disease)

• 1993 – 1995: works at the Laboratory of Ultrastrutture for the graduation thesis, National Institute of Health, Rome • 1996 – 1997: apprenticeship in Pharmacology, Pharmacognosy and Toxicology, Inst. Pharmacology, University La Sapienza, Rome, tutor Prof. B. Silvestrini. • 1998 – 2000: Telethon Foundation grant fellowship (Department of Neuroscience, University of Rome “Tor Vergata”, directed by Prof. Paolo Calabresi) titled “Mechanisms underlying cell-type specific vulnerability of striatal neurons: implications for Huntington’s disease”. • 2001 - 2004: PhD student at Department of Neuroscience, University of Rome “Tor Vergata” and Laboratory of Neurophysiology, Fondazione Santa Lucia Rome, tutor Professor Calabresi. • 2002 - During PhD period spent a period of fellowship in the Laboratory of Neurobiology tutor by Prof. M. Angela Cenci, Wallenberg Centre, University of Lund, Sweden, aimed to the improving of behavioral tests in parkinsonian animal models. • 2Feb2005: Obtain the PhD in Neuroscience at Department of Neuroscience, University of Rome “Tor Vergata”. • From 2005 - 2018: Researcher - Laboratory of Neurophysiology, Santa Lucia Foundation, Rome, Italy. • 16Mar2018: Associate Professor in Physiology, San Raffaele University, Rome, Italy. • From Jul 2018: Head of Laboratory of Experimental Neurophysiology, IRCCS San Raffaele University, Rome, Italy.

Neurodegenerative Disease and Behavioural Neurology

David J Brooks MD DSc FRCP(UK) FMed Sci (UK) is Professor of Clinical PET Research at Newcastle University, Professor of Neurology at Aarhus University, Denmark, and Visiting Professor of Neurology at Imperial College London, UK. He is Chairman of the European Research Council Advanced Neuroscience Panel and is on the Grant Awards Board of Alzheimer Research UK, the Biomedical Research Advisory Panel of Alzheimer UK, and was on the Scientific Advisory Boards of Parkinson’s UK, and the German Dementia and the Parkinson Kompetenz Networks. He was Chairman of the NUHS Scientific Advisory Panel, Singapore, in 2015 and is a reviewer for the NMRC, Singapore. He was a member of the Scientific Advisory Board of the Michael J. Fox Foundation for Parkinson's Disease Research (2002-2006), UK Medical Research Council Neuroscience and Mental Health Board (2004-2007), Wellcome Trust Neuroscience Panel (2001-2003) and was Chairman of the Scientific Issues Committee of the Movement Disorder Society (1998-2002). He is an Associate Editor of Brain and is on the Editorial Boards of Annals of Neurology, Molecular Imaging and Biology, Journal of Parkinson’s Disease, Synapse, NPJ Parkinson’s Disease and Basal Ganglia. He was on the Editorial Boards of Movement Disorders 1994-1998 and Parkinsonism and Related Disorders 2012-2016. In 2001 he was elected a Fellow of the Academy of Medical Science, UK and is a Fellow of the American Neurology Association. His research involves the use of positron emission tomography and magnetic resonance imaging to diagnose and study the progression of Alzheimer’s and Parkinson’s disease and his work is highly cited with an h index of 112. He has been a recipient of the Ramon Y Cajal award from the Spanish Medical Academy, the Danish Alzheimer Foundation Prize, the Kuhl-Lassen award (Society of Nuclear Medicine), and was invited to give the Stahn Fahn (International Movement Disorder Society) and Cotzias (Spanish Neurology Society) and Ramon Y Cajal (Spanish Medical Academy) Lectures. He is currently a consultant for GE Healthcare and Biogen.

His research involves the use of positron emission tomography and magnetic resonance imaging to diagnose and study the progression of Alzheimer’s and Parkinson’s disease and his work is highly cited with an h index of 112.

I have completed my PhD in Cellular, Molecular and Industrial Biology from the University of Bologna (UNIBO), Italy under Indo-Italian Government fellowship in 2012. After completion of my PhD, I received four and a half years of Postdoctoral training from the University of Kansas Medical Center, Kansas City, USA there I worked on Translational Cancer Research. During my Postdoctoral training, I worked on several cancers, including Prostate, Pancreatic, Breast and Head and Neck Cancer. First two and a half years of my postdoctoral training was focused on understanding the molecular mechanism (s) of the regulation of Autophagy and Apoptosis in Cancer Stem Cells (Prostate, Pancreatic and Breast). Specifically, I studied the molecular mechanism (s) of Rottlerin-induced Autophagy in Cancer Stem Cells (CSCs) via PI3K/Akt/mTOR signaling pathways. Later, I investigated the molecular cross-talk between the tumor microenvironment (Tumor Associated Fibroblast (TAF)) and Head and Neck Squamous Cell Carcinoma (HNSCC) via HGF/c-MET and bFGF/FGFR signaling pathways. In addition, I also worked on intra-tumor mutational heterogeneity in Head and Neck Squamous Cell Carcinoma, developed an in vitro model for Radiation Induced Fibrosis (RIF) in Head and Neck Cancer, molecular mechanism (s) of combination of naturally derived chemo-preventive agents (Curcumin in combination with other anticancer compounds) in Head and Neck Squamous Cell Carcinoma and the characterization of exosomes released from cancer stem cells (CSCs). My research work has been published in high impact international research journals including Cancer Research [Impact Factor: 9.122], Radiation Research [Impact Factor: 2.775], Oncotarget [Impact Factor: 5.168], JAMA Otolaryngoogy - Head Neck Surgery [Impact Factor: 2.95], Human Molecular Genetics [Impact Factor: 5.985], Cancer Letters [Impact Factor: 6.375], Pharmacology & Therapeutics [Impact Factor: 11.127], Molecular Cancer [Impact Factor: 6.204], Oncogenesis [Impact Factor: 5.1], PLoS One [Impact Factor: 2.806], Biochemical Pharmacology [Impact Factor: 5.009]. Apart from my research, I was also involved in teaching courses of Undergraduate Level (BIOT223-Basics of Cancer), Postgraduate Level (MMBS602: Gene Expression & Regulation, MMBS610: Topics in Bioinformatics, MMBS702: Computational Tools in Drug Discovery, SCCB710: OMICS in Biomedical Sciences, SCCB601: Animal Cell Culture & Cell Engineering, SCCB603: Genome Engineering & Editing, SCCB705: Preventive Oncology & Psycho-Oncology) and PhD Level (BIOT 953: Advances in Cancer Research).

 Translational Cancer Research  Cancer Stem Cell  Drug Discovery  Tumor Microenvironment  Molecular Immunology  Cellular Aging  Autophagy  Neurodegenerative Disease  Next Generation Sequencing (NGS)  Bioinformatics

An accomplished scientist and academician with Ph.D. in Biochemistry and over 10 years of experience of conducting active research and teaching in the field of neuro-degeneration and nutrition. - Strong technical expertise in latest molecular, cellular biology tools and behavioral assessments-Served as PI and Co-PI for grants awarded and through collaboration with leading research institutes globally (total 10 grants). -118 publications, Authored, co-authored and edited many books. - Editor in Chief for a Scopus indexed international journal (www.ijnpnd.com); Academic Editor for BMC journal and Special issue editor for Frontiers in Biosciences -Supervised three graduate students for their Ph.D. degree. Visiting professor at NIH (USA), Macquarie University (Australia) and University of New South Wales (Australia). Have been chairperson and member of research committees.-Organized conferences to promote research in the field of neurocognitive diseases and nutritional approaches.-Have been invited as guest speaker and chairperson for many national and international conferences.-Bagged many awards for the active contribution in the field.

The primary focus of my research interest is to establish a world class Behavior, Nutrition and Neuropharmacology research facility to study a broad area of neuro degenerative disorders at behavioral, biochemical, nutritional, molecular & signaling level. My main area of research is on Nutritional Neuroscience: the effect of dietary supplements on Neurodegenerative diseases transgenic mouse models and human primary neurons. Considering the limits of existing preventive methods, intervention strategies using diet, nutrients, antioxidant and flavonoid rich natural products such as fruits, vegetables and nuts are of paramount importance. As this area of research in neurodegenerative diseases is still in the early phase, I am eager to establish a state of the art research facility for neurodegenerative diseases to study the molecular mechanisms underlying the selective vulnerability of neuronal populations which degenerate in people with neurodegenerative disorders and the effect on diet and nutraceuticals on them.

Dr. Nadeem Kizilbash received his Ph.D. in Biophysics from Boston University (USA) in 2003. His doctoral thesis was titled: “Biophysical Studies of Fatty Acid Binding Proteins and Hydrophobic Ligands”. He completed a postdoctoral fellowship at Penn State University (USA) and is presently serving as Head & Assistant Professor of Biochemistry at Northern Border University (Saudi Arabia).

He has published a monograph in 2013 and is the author of more than 40 international publications in the areas of Structural Biology, Protein Chemistry, Drug Delivery, Gene Polymorphism, Oncology, Endocrinology, Toxicology and Medicinal Chemistry.

• Psychology department (BSc), School of Philosophy, Aristotle University of Thessaloniki (Oct 2010 – July 2014). • Master of Science (MSc) in Medical School of Aristotle University of Thessaloniki “Medical Research and Methodology" (Oct 2014 – Oct 2016), “Excellent 9”. • Master of Science (MSc) in School of Mathematics of Aristotle University of Thessaloniki “Complex Systems and Networks” (Oct 2017 – Dec 2018) (“Very Good 8” - everything except dissertation). • PhD candidate (PhDc) in Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 1st Department of Neurology U.H. “AHEPA” (June 2018 – June 2022)

Professor Cai Song obtained her BSc in Biology and MSc in Neurophysiology from the East China Normal University, PhD in Neuropharmacology from National University of Ireland, and postdoctoral training in McGill and Carleton Universities, Canada. She was an Assistant Professor in Psychiatry Dept. University of British Columbia, Associate Professor in University of Prince Edward Island (UPEI), and Canada Research Chair in Canada National Institute of Nutrition and Health and UPEI. Since 2013, she is the director and professor of Research Institute for Marine Drugs and Nutrition, Guangdong Ocean University, China and Psychiatry Department of China Medical University, Taiwan.

Her research areas: 1) The interaction between the CNS and immune systems in normal and psychiatric diseases; 2) the contribution of inflammatory processes to neurodegenerative diseases; (3) the development of low side-effect treatments (including drugs and natural products) that have anti- inflammatory and neuroprotective properties.

Member of Iran’s National Elites Foundation (Bonyad Melli Nokhbegan) Member of Talented Students Office, Tabriz University of Medical Sciences Member of Talented Students Office, Kerman University of Medical Sciences Member of Talented Students Office, Tehran University of Medical Sciences

1- Principles of Epidemiology, 2- Principles of Epidemiology 3- Research Methodology, 5- Advanced Statistical Methods 5- Biostatistics 5- Geographical Pathology

Gaetano Barbagallo obtained his Medical Degree in Neurology (Catanzaro, 2015), after a visiting period at Clinical Investigation Centre and INSERM U825 (Toulouse, France). As a neurologist and research fellow at Institute of Neurology of Magna Graecia University, Dr. Barbagallo’s main fields of interest are Parkinson’s disease, movement and cognitive disorders.

He is currently working at several research projects on neuroimaging methods (i.e. multimodal MRI, proton MR spectroscopy, medicine nuclear techniques) to gather information about the structural and functional brain changes related to neurodegenerative diseases.

 Preparation of nano crystalline metal oxide and composite powders/films using Electrochemical, chemical, sol-gel and combustion synthesis routes for gas sensors and catalysis for waste effluent treatment.  Deposition of metal oxide thin films using Thermal Evaporation and Electron beam evaporation techniques useful for solar cells and dye sensitized solar cells.  Characterization of physical and Chemical properties of Nano semiconductor powders/hard coatings/metal oxide films (XRD, TEM, XPS, AFM, SEM, FTIR, Raman shift, NMR, ESR, Uv-Vis, Electrochemical impedance characterization techniques)

 Research experience in Nanomaterials, Biomaterials and Materials Science & Nanotechnology.

Ángela Milán obtained her Medical Degree in Neurology (Palma de Mallorca, Spain 2014) after doing an observership in the Sleep Unit at Toronto Western Hospital. She completed four year fellowships at Toronto, Canada (Research Fellow in Sleep Medicine at Toronto Western Hospital and Clinical-Research Fellow in Cognitive Neurology and Movement disorders at Sunnybrook Health Sciences Centre 2014-2018). Since March 2018 she coordinates the Cognitive and Behavioral unit at Clinica Universidad de Navarra in Madrid, Spain. She is preparing her PhD in the field of pharmacogenetics in Alzheimer´s and Parkinson´s disease.

1. The utility of sleep biomarkers in Neurodegenerative disease (Parkinson's Disease). Polysomnography as a tool diagnosing depression in Parkinson population. 2. Topography and frequency of cerebreal microbleeds across different neurodegenerative disease, neuroimaging and genetic biomarkers in a cohort of patients. 3. Participating as PI in research trials in Alzheimer disease.

Dr Mostafa Afify has completed his Doctorate degree in Forensic Medicine &Clinical Toxicology in 2009, from Faculty of Medicine, Cairo University, Egypt. He started his academic career at Beni-Suef University where he serves now as an associate Professor of Forensic Medicine &Clinical Toxicology. He was Former Vice Dean for Community Service and Environmental Development in the period 2015-2016 in the same University. He is currently a consultant of Clinical Toxicology and forensic chemistry in Dammam Poison Control Center, MOH - Saudi Arabia. He supervised a number of 4 MD & 7 MSc theses. He published many research articles and serves as reviewer and as an editorial member of some specialized peer-reviewed journals. He is also a member of many specialized societies.

Forensic Medicine; Forensic pathology; DNA fingerprinting; Human Identification; Crime scene investigation, Forensic Genetics; forensic odontology; Forensic Toxicology; Clinical Toxicology; Analytical Toxicology; Environmental Toxicology; Drug and Alcohol Abuse; Medical Ethics.

Im assistant professor of neurology from 2015, working in Roozbeh Hospital which is a Center of psychiatry and Neuropsychiatry at Tehran University of Medical Sciences, I have been a member of Iranian Neurology Association since 2011 and ILEA branch of Iran since 2017. I had been resident of neurology from 2007-2011 at Tehran University of Medical Sciences, and medical doctorate student from 1997 to 2004 at Isfahan University of Medical Sciences. Throughout my career I have been active in medical student and residency education. I have been especially interested in teaching students in beginning years of general medicine duration, thorough research projects. Since 20015 I have been thesis advisor and co advisor of 28 students.

My current research projects focus on Dementia (Neurocognition), Abnormal movements, Neuropsychiatry and Epilepsy.

Ivan V. Maksimovich, MD, PhD, professor, who at the present time is an Academician of the Russian Academy of Medical and Technical Sciences, is a member of the Russian Association of Cardiovascular Surgeons, the Russian Scientific Society of Specialists in Endovascular Diagnosis and Treatment, the All-Russian Scientific Society of Interventional Radiologists and Endovascular Surgeons, the Alzheimer's Association International Society for Advance Alzheimer's Research and Treatment (ISTAART), European Society of Cardiology (ESC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), World Stroke Organization (WSO), European Stroke Organization (ESO) and European Psychiatric Association (EPA).

The main direction is the treatment of vascular diseases of the brain, dementia, Alzheimer's disease, Binswanger's Disease.